Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

The hazard of the progression of intermediate age-related macular degeneration (iAMD) was higher in those whose complement ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

DataM Intelligence | competitive Intelligence GA treatment market heats up: Syfovre & Izervay lead, while oral, gene, cell therapies and AI ...

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with ...

Geographic Atrophy: Latest Treatments for Personalized Approaches This activity is supported by educational grants from Apellis Pharmaceuticals, Inc.; Astellas; and Topcon Healthcare, Inc.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious neurological and ...

Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...